News

May 10th
2017

BroadPharm has filed a new non-provisional US patent for PEGylated cyanines.

BroadPharm, a leading customer-focused biotech company, has filed a new patent which covers functionalized PEGylated cyanine compounds and their applications. The incorporation of PEG into cyanine dyes has greatly improved the dye’s hydrophilicity. The introduction of a variety of functional groups broadens the applications of these cyanine dyes in biolabeling, imaging and other fields.

“The filing of this new patent will further strengthen BroadPharm's leading position in PEGylation and biolabeling field.” said David Zhang, Chief Executive Officer of BroadPharm.

For products, go to http://bit.ly/2q4gX0L.

May 1st
2017

BroadPharm has recently introduced a broad range of new compounds used for Click Chemistry.

Click Chemistry has been widely used in pharmaceutical and biotech industry for more than 10 years due to its mild conditions and biocompatibility. BroadPharm has integrated our bestselling “PEG Linkers” products into the traditional Click Chemistry reagents to make the new reagents more water-soluble and biocompatible.

We have over 400 new Click Chemistry reagents with a broad range of functional groups. To see these advanced products, go to http://bit.ly/2oQHP07.

 

For more information, stay connected with us for the latest news and our newly released products.